VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_14-vv-00285
Package ID: USCOURTS-cofc-1_14-vv-00285
Petitioner: Ofelia Winters
Filed: 2015-05-13
Decided: 2015-06-03
Vaccine: influenza
Vaccination date: 
Condition: purpuric lesions, vasculitis, panniculitis
Outcome: compensated
Award amount USD: 110916

AI-assisted case summary:
Ofelia Winters filed a petition on May 13, 2015, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered purpuric lesions, vasculitis, and panniculitis as a result of receiving an influenza vaccine and/or a tetanus-diphtheria-acellular pertussis (Tdap) vaccine. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused Ms. Winters' conditions. However, both parties agreed to settle the case through a stipulation filed on May 13, 2015. The stipulation proposed awarding Ms. Winters compensation for all damages available under the program. The Special Master reviewed the file and found the stipulation to be reasonable, adopting it as the decision. Ms. Winters was awarded a lump sum of $110,916.36, payable to her, as compensation for all damages. The clerk of the court was directed to enter judgment accordingly.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_14-vv-00285-0
Date issued/filed: 2015-06-03
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 5/13/2015) regarding 27 DECISION Stipulation. Signed by Special Master Brian H. Corcoran. (ag) Copy to parties.
--------------------------------------------------------------------------------
Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 14-285V
(Not to be published)
* * * * * * * * * * * * * * * * * * * * * * * * * * * * *
*
OFELIA WINTERS, *
*
Petitioner, * Filed: May 13, 2015
*
v. * Decision by Stipulation; Damages;
* Influenza (“Flu”) Vaccine;
* Tetanus-diphtheria-acellular
SECRETARY OF HEALTH AND * pertussis (“Tdap”); Vasculitis;
HUMAN SERVICES, * Panniculitis
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Clifford John Shoemaker, Shoemaker, Gentry & Knickelbein, Vienna, VA, for Petitioner.
Lisa Watts, U.S. Dep’t of Justice, Washington, DC, for Respondent
DECISION AWARDING DAMAGES1
On April 11, 2011, Petitioner Ofelia Winters filed a petition seeking compensation under
the National Vaccine Injury Compensation Program, (“the Vaccine Program”).2 Petitioner
alleges that she suffered purpuric lesions, vasculitis, panniculitis, and related complications as a
result of receiving an influenza (“flu”) vaccine and/or a tetanus-diphtheria-acellular pertussis
(“Tdap”).
1 Because this decision contains a reasoned explanation for my action in this case, I will post this decision on the
United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No.
107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42
U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the posted decision’s inclusion of certain kinds of
confidential information. Specifically, under Vaccine Rule 18(b), each party has 14 days within which to request
redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in
substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which
would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will
be available to the public. (Id.)
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C.A. ' 300aa-10-' 300aa-34
(West 1991 & Supp. 2002). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A.
' 300aa.

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 2 of 7
Respondent denies that Petitioner’s purpuric lesions, vasculitis, panniculitis, and any
related medical problems were caused by the receipt of the flu of Tdap vaccines. Nonetheless
both parties, while maintaining their above-stated positions, agreed in a stipulation filed May 13,
2015, that the issues before them can be settled and that a decision should be entered awarding
Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’
stipulation is reasonable. I therefore adopt it as my decision in awarding damages on the terms
set forth therein.
The stipulation awards:
A lump sum of $110,916.36, in the form of a check payable to petitioner. This
amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a).
Stipulation ¶ 8.
I approve a Vaccine Program award in the requested amount set forth above to be made
to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the
clerk of the court is directed to enter judgment herewith.3
IT IS SO ORDERED.
/s/ Brian H. Corcoran
Brian H. Corcoran
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice renouncing
their right to seek review.
2

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 3 of 7

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 4 of 7

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 5 of 7

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 6 of 7

Case 1:14-vv-00285-UNJ Document 31 Filed 06/03/15 Page 7 of 7